Travel-associated multidrug-resistant organism acquisition and risk factors among US military personnel

被引:7
|
作者
Buchek, Gregory [1 ,2 ]
Mende, Katrin [1 ,3 ,4 ]
Telu, Kalyani [3 ,4 ]
Kaiser, Susan [1 ,3 ,4 ]
Fraser, Jamie [3 ,4 ]
Mitra, Indrani [3 ,4 ]
Stam, Jason [5 ]
Lalani, Tahaniyat [3 ,4 ]
Tribble, David [3 ]
Yun, Heather C. [1 ,2 ]
机构
[1] Brooke Army Med Ctr, Jbsa Ft Sam Houston, TX 78234 USA
[2] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[3] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Infect Dis Clin Res Program, Bethesda, MD 20814 USA
[4] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA
[5] Walter Reed Army Inst Res, Silver Spring, MD USA
基金
美国国家卫生研究院;
关键词
ESBL-producing Enterobacteriaceae; Eschericia coli; Perirectal swab; Colonization; Whole genome sequencing; CTX-M; Antimicrobials; INTERNATIONAL TRAVEL; COLONIZATION; BACTERIA; ENTEROBACTERIACEAE; INFECTION;
D O I
10.1093/jtm/taab028
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: International travel is a risk factor for incident colonization with extended spectrum beta-lactamase (ESBL)-producing organisms. These and other multidrug-resistant (MDR) bacteria are major pathogens in combat casualties. We evaluated risk factors for colonization with MDR bacteria in US military personnel travelling internationally for official duty. Methods: TravMil is a prospective observational study enrolling subjects presenting to military travel clinics. We analysed surveys, antimicrobial use data, and pre- and post-travel perirectal swabs in military travellers to regions outside the continental USA, Canada, Western or Northern Europe, or New Zealand, presenting to one clinic from 12/2015 to 12/2017. Recovered Gram-negative isolates underwent identification and susceptibility testing (BD Phoenix). Characteristics of trip and traveller were analysed to determine risk factors for MDR organism colonization. Results: 110 trips were planned by 99 travellers (74% male, median age 38 years [IQR 31, 47.25]); 72 trips with returned pre- and post-travel swabs were completed by 64 travellers. Median duration was 21 days (IQR 12.75, 79.5). 17% travelled to Mexico/Caribbean/Central America, 15% to Asia, 57% to Africa and 10% to South America; 56% stayed in hotels and 50% in dormitories/barracks. Travellers used doxycycline (15%) for malaria prophylaxis, 11% took an antibiotic for travellers' diarrhoea (TD) treatment (fluoroquinolone 7%, azithromycin 4%). Incident MDR organism colonization occurred in 8 travellers (incidence density 3.5/1000 travel days; cumulative incidence 11% of trips [95% CI: 4-19%]), all ESBL-producing Escherichia coli. A higher incidence of ESBL-producing E. coli acquisition was associated with travel to Asia (36% vs 7%, P=0.02) but not with travel to other regions, TD or use of antimicrobials. No relationship was seen between fluoroquinolone or doxycycline exposure and resistance to those antimicrobials. Conclusions: Incident colonization with MDR organisms occurs at a lower rate in this military population compared with civilian travellers, with no identified modifiable risk factors, with highest incidence of ESBL acquisition observed after South Asia travel.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Travel and acquisition of multidrug-resistant Enterobacteriaceae
    Armand-Lefevre, L.
    Andremont, A.
    Ruppe, E.
    MEDECINE ET MALADIES INFECTIEUSES, 2018, 48 (07): : 431 - 441
  • [2] Multidrug-resistant Acinetobacter infections in US military personnel, 2003 to 2005
    Davis, Kepler A.
    Moran, Kimberly A.
    EMERGING INFECTIONS 7, 2007, 7 : 309 - +
  • [3] Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patients
    Fukuta, Yuriko
    Muder, Robert R.
    Agha, Mounzer E.
    Clarke, Lloyd G.
    Wagener, Marilyn M.
    Hensler, Amelia M.
    Doi, Yohei
    AMERICAN JOURNAL OF INFECTION CONTROL, 2013, 41 (12) : 1249 - 1252
  • [4] Factors associated with bacteraemia due to multidrug-resistant organisms among bacteraemic patients with multidrug-resistant organism carriage: a case control study
    Hélène Mascitti
    Clara Duran
    Elisabeth-Marie Nemo
    Frédérique Bouchand
    Ruxandra Câlin
    Alexis Descatha
    Jean-Louis Gaillard
    Christine Lawrence
    Benjamin Davido
    François Barbier
    Aurélien Dinh
    Antimicrobial Resistance & Infection Control, 7
  • [5] Factors associated with multidrug-resistant organism (MDRO) mortality: an analysis from the national surveillance of multidrug-resistant organism, 2018-2022
    Sharifa Ezat WP
    M Norhidayah
    Muhammad Nur Amir AR
    BMC Infectious Diseases, 25 (1)
  • [6] Multidrug-resistant gram-negative bacteria colonization of healthy US military personnel in the US and Afghanistan
    Vento, Todd J.
    Cole, David W.
    Mende, Katrin
    Calvano, Tatjana P.
    Rini, Elizabeth A.
    Tully, Charla C.
    Zera, Wendy C.
    Guymon, Charles H.
    Yu, Xin
    Cheatle, Kristelle A.
    Akers, Kevin S.
    Beckius, Miriam L.
    Landrum, Michael L.
    Murray, Clinton K.
    BMC INFECTIOUS DISEASES, 2013, 13
  • [7] Multidrug-resistant gram-negative bacteria colonization of healthy US military personnel in the US and Afghanistan
    Todd J Vento
    David W Cole
    Katrin Mende
    Tatjana P Calvano
    Elizabeth A Rini
    Charla C Tully
    Wendy C Zera
    Charles H Guymon
    Xin Yu
    Kristelle A Cheatle
    Kevin S Akers
    Miriam L Beckius
    Michael L Landrum
    Clinton K Murray
    BMC Infectious Diseases, 13
  • [8] Gram-Negative Multidrug-Resistant Organism Colonization in a US Military Healthcare Facility in Iraq
    Ake, Julie
    Scott, Paul
    Wortmann, Glenn
    Huang, Xiao-Zhe
    Barber, Melissa
    Wang, Zhining
    Nikolich, Mikeljon
    Van Echo, David
    Weintrob, Amy
    Lesho, Emil
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2011, 32 (06): : 545 - 552
  • [9] Assessment of risk factors associated with multidrug-resistant organism infections among patients admitted in a tertiary hospital- a retrospective study
    Alsehemi, Alaa F.
    Alharbi, Emad A.
    Alammash, Buthainah B.
    Alrais, Alaa I.
    Elbadawy, Hossein M.
    Alahmadi, Yaser M.
    SAUDI PHARMACEUTICAL JOURNAL, 2023, 31 (06) : 1084 - 1093
  • [10] Risk factors for acquisition of multidrug-resistant Enterobacterales among international travellers: a synthesis of cumulative evidence
    Furuya-Kanamori, Luis
    Stone, Jennifer
    Yakob, Laith
    Kirk, Martyn
    Collignon, Peter
    Mills, Deborah J.
    Lau, Colleen L.
    JOURNAL OF TRAVEL MEDICINE, 2020, 27 (01)